We are live on
!
Find out more
TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
1-Year Est. Return
15.44%
This Fund
S&P 500
This Quarter
Est. Return
+7.45%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$26.2M
(+3.6%)
Cap. Flow
-$6.76M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
43.11%
Holding
80
New
2
Increased
27
Reduced
31
Closed
4
Top Buys
| 1 |
Brown-Forman Class B
BF.B
|
+$1.14M |
| 2 |
Illinois Tool Works
ITW
|
+$851K |
| 3 |
Mettler-Toledo International
MTD
|
+$707K |
| 4 |
United Parcel Service
UPS
|
+$657K |
| 5 |
Verizon
VZ
|
+$405K |
Top Sells
| 1 |
Kimberly-Clark
KMB
|
+$6.62M |
| 2 |
Fortive
FTV
|
+$3.01M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.26M |
| 4 |
General Mills
GIS
|
+$996K |
| 5 |
Unilever
UL
|
+$907K |
Sector Composition
| 1 | Healthcare | 47.03% |
| 2 | Technology | 10.37% |
| 3 | Industrials | 9.39% |
| 4 | Consumer Discretionary | 6.32% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
1
DELISTED
Tiffany & Co.
TIF
| $44.8M | 5.95% |
340,190
-2,146
| -0.6% | -$245K |
|
2
Neogen
NEOG
$2.25B
| $36.6M | 4.86% |
912,060
-5,632
| -0.6% | -$208K |
|
3
Cognex
CGNX
$10.6B
| $33.1M | 4.4% |
741,675
+2,275
| +0.3% | +$108K |
|
4
Idexx Laboratories
IDXX
$45.4B
| $33M | 4.38% |
151,280
-1,950
| -1% | -$402K |
|
5
Analog Devices
ADI
$185B
| $31.9M | 4.24% |
332,845
+1,150
| +0.3% | +$109K |
|
6
Mastercard
MA
$487B
| $30.6M | 4.07% |
155,666
+51
| +0% | +$9.59K |
|
7
Inogen
INGN
$180M
| $30.6M | 4.06% |
164,115
-3,800
| -2% | -$632K |
|
|
ABMD
8
DELISTED
Abiomed Inc
ABMD
| $30.2M | 4.02% |
73,940
-6,240
| -8% | -$2.26M |
|
9
DexCom
DXCM
$30.1B
| $27.6M | 3.66% |
1,160,816
+1,500
| +0.1% | +$31.8K |
|
10
Insulet
PODD
$11.4B
| $26.1M | 3.46% |
304,165
+1,125
| +0.4% | +$101K |
|
|
RTN
11
DELISTED
Raytheon Company
RTN
| $25.9M | 3.44% |
134,139
+817
| +0.6% | +$172K |
|
|
12
Brown-Forman Class B
BF.B
$11.9B
| $24.5M | 3.26% |
500,364
+20,828
| +4% | +$1.14M |
|
13
Danaher
DHR
$145B
| $24.3M | 3.23% |
278,053
-264
| -0.1% | -$23.5K |
|
14
Johnson & Johnson
JNJ
$602B
| $23.9M | 3.18% |
197,245
+954
| +0.5% | +$119K |
|
15
Honeywell
HON
$71.7B
| $22.9M | 3.04% |
175,950
+306
| +0.2% | +$40.7K |
|
16
Biogen
BIIB
$30.8B
| $20.7M | 2.75% |
71,357
-870
| -1% | -$245K |
|
|
NVO
17
Novo Nordisk
NVO
$228B
| $18.8M | 2.5% |
814,890
+2,900
| +0.4% | +$68.9K |
|
18
Ross Stores
ROST
$74.7B
| $18.6M | 2.48% |
219,759
-1,224
| -0.6% | -$99.6K |
|
19
Starbucks
SBUX
$124B
| $15.8M | 2.1% |
323,738
-7,635
| -2% | -$433K |
|
20
Henry Schein
HSIC
$10.1B
| $14.5M | 1.92% |
253,933
+2,678
| +1% | +$151K |
|
21
Amgen
AMGN
$201B
| $14.1M | 1.88% |
76,445
-579
| -0.8% | -$102K |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $13.8M | 1.84% |
173,170
+4,365
| +3% | +$362K |
|
|
23
Mettler-Toledo International
MTD
$27B
| $13.5M | 1.8% |
23,350
+1,240
| +6% | +$707K |
|
24
AbbVie
ABBV
$449B
| $11.5M | 1.52% |
123,700
-850
| -0.7% | -$83K |
|
25
State Street
STT
$51.4B
| $10.8M | 1.44% |
116,308
+2,049
| +2% | +$203K |
|
Similar funds
IAS
ACM
MFBTD
SGAM
AB
NTC
DCM
DSI